Oculis Holding AG (OCS) Change in Taxes (2023 - 2026)
Oculis Holding AG's (OCS) quarterly Change in Taxes came in at -$8939.0 in Q1 2026, up 42.59% year-on-year from -$6268.9 in Q1 2025, and down 223.34% quarter-over-quarter from $7247.3 in Q2 2025.
Oculis Holding AG (OCS) Change in Taxes (2023 - 2026) Analysis & Trends
Oculis Holding AG's Change in Taxes history runs 4 years deep, the most recent figure standing at -$8939.0 for Q1 2026.
- On a quarterly basis, Change in Taxes rose 42.59% year-over-year to -$8939.0 in Q1 2026; TTM through Mar 2026 was -$149679.7, a 15.56% increase from a year earlier, with the FY2024 full-year figure at -$172778.6, down 53.64% from the prior year.
- Change in Taxes eased to -$8939.0 in Q1 2026 per OCS's latest filing, from $7247.3 in the prior quarter.
- Across five years, Change in Taxes topped out at $65386.6 in Q4 2023 and bottomed at -$132416.5 in Q4 2024.
- The 4-year median for Change in Taxes is -$11456.8 (2024), against an average of -$10999.3.
- Across the five-year window, Change in Taxes sank 302.51% in 2024 and surged 143.69% in 2025, its largest moves.
- Year by year, Change in Taxes stood at $65386.6 in 2023, then sank by 302.51% to -$132416.5 in 2024, then surged by 105.47% to $7247.3 in 2025, then plunged by 223.34% to -$8939.0 in 2026.
- Per Business Quant, the three latest OCS Change in Taxes figures stand at -$8939.0 (Q1 2026), $7247.3 (Q2 2025), and -$15571.5 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,939.03 |
| Mar 31, 2026 | -8,939.03 |
| Jun 30, 2025 | 7,247.34 |
| Jun 30, 2025 | 7,247.34 |
| Mar 31, 2025 | -15,571.51 |
| Mar 31, 2025 | -15,571.51 |
| Dec 31, 2024 | -132,416.53 |
| Dec 31, 2024 | -132,416.53 |
| Sep 30, 2024 | -12,696.28 |
| Sep 30, 2024 | -12,696.28 |
| Jun 30, 2024 | -16,586.90 |
| Jun 30, 2024 | -16,586.90 |
| Mar 31, 2024 | -11,456.82 |
| Mar 31, 2024 | -11,456.82 |
| Dec 31, 2023 | 65,386.56 |
| Dec 31, 2023 | 65,386.56 |
| Sep 30, 2023 | 26,039.51 |
| Sep 30, 2023 | 26,039.51 |